Global 4 Factor Pro-thrombin Complex Concentrate Market Growth 2025-2031
Description
The global 4 Factor Pro-thrombin Complex Concentrate market size is predicted to grow from US$ 1128 million in 2025 to US$ 2243 million in 2031; it is expected to grow at a CAGR of 12.1% from 2025 to 2031.
The 4-factor prothrombin complex concentrate (4F-PCC), which contains the human coagulation factors II, VII, IX and X together with the endogenous inhibitor proteins S and C, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by VKA (e.g. warfarin or coumarin) therapy in adult
The market factors is increasing prescription of anticoagulants, especially warfarin, as well as rising prevalence of bleeding disorders. Additionally, PCC offers various advantages over Fresh-frozen plasma and others, making it a more suitable option for life-threatening conditions. Apart from this, active government support for the use of 4-factor PCC products such as Kcentra and positive recommendations are anticipated to provide considerable momentum to the market.
LP Information, Inc. (LPI) ' newest research report, the “4 Factor Pro-thrombin Complex Concentrate Industry Forecast” looks at past sales and reviews total world 4 Factor Pro-thrombin Complex Concentrate sales in 2024, providing a comprehensive analysis by region and market sector of projected 4 Factor Pro-thrombin Complex Concentrate sales for 2025 through 2031. With 4 Factor Pro-thrombin Complex Concentrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 4 Factor Pro-thrombin Complex Concentrate industry.
This Insight Report provides a comprehensive analysis of the global 4 Factor Pro-thrombin Complex Concentrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 4 Factor Pro-thrombin Complex Concentrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 4 Factor Pro-thrombin Complex Concentrate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 4 Factor Pro-thrombin Complex Concentrate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 4 Factor Pro-thrombin Complex Concentrate.
This report presents a comprehensive overview, market shares, and growth opportunities of 4 Factor Pro-thrombin Complex Concentrate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Beriplex
Octaplex
Prothromplex
Cofact
Other
Segmentation by Application:
Hemophilia B
Acquired Coagulation Factor Deficiency
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CSL Behring
Octapharma
Prothya Biosolutions
Takeda
Key Questions Addressed in this Report
What is the 10-year outlook for the global 4 Factor Pro-thrombin Complex Concentrate market?
What factors are driving 4 Factor Pro-thrombin Complex Concentrate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 4 Factor Pro-thrombin Complex Concentrate market opportunities vary by end market size?
How does 4 Factor Pro-thrombin Complex Concentrate break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The 4-factor prothrombin complex concentrate (4F-PCC), which contains the human coagulation factors II, VII, IX and X together with the endogenous inhibitor proteins S and C, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by VKA (e.g. warfarin or coumarin) therapy in adult
The market factors is increasing prescription of anticoagulants, especially warfarin, as well as rising prevalence of bleeding disorders. Additionally, PCC offers various advantages over Fresh-frozen plasma and others, making it a more suitable option for life-threatening conditions. Apart from this, active government support for the use of 4-factor PCC products such as Kcentra and positive recommendations are anticipated to provide considerable momentum to the market.
LP Information, Inc. (LPI) ' newest research report, the “4 Factor Pro-thrombin Complex Concentrate Industry Forecast” looks at past sales and reviews total world 4 Factor Pro-thrombin Complex Concentrate sales in 2024, providing a comprehensive analysis by region and market sector of projected 4 Factor Pro-thrombin Complex Concentrate sales for 2025 through 2031. With 4 Factor Pro-thrombin Complex Concentrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 4 Factor Pro-thrombin Complex Concentrate industry.
This Insight Report provides a comprehensive analysis of the global 4 Factor Pro-thrombin Complex Concentrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 4 Factor Pro-thrombin Complex Concentrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 4 Factor Pro-thrombin Complex Concentrate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 4 Factor Pro-thrombin Complex Concentrate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 4 Factor Pro-thrombin Complex Concentrate.
This report presents a comprehensive overview, market shares, and growth opportunities of 4 Factor Pro-thrombin Complex Concentrate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Beriplex
Octaplex
Prothromplex
Cofact
Other
Segmentation by Application:
Hemophilia B
Acquired Coagulation Factor Deficiency
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CSL Behring
Octapharma
Prothya Biosolutions
Takeda
Key Questions Addressed in this Report
What is the 10-year outlook for the global 4 Factor Pro-thrombin Complex Concentrate market?
What factors are driving 4 Factor Pro-thrombin Complex Concentrate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 4 Factor Pro-thrombin Complex Concentrate market opportunities vary by end market size?
How does 4 Factor Pro-thrombin Complex Concentrate break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
85 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for 4 Factor Pro-thrombin Complex Concentrate by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for 4 Factor Pro-thrombin Complex Concentrate by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
